Dr. Aburashed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Insight Hospital & Medical Center
2525 S Michigan Ave
Chicago, IL 60616Phone+1 989-723-1390Fax+1 989-725-1415
Education & Training
University of Michigan Health - Sparrow/Michigan State UniversityResidency, Neurology, 2007 - 2010
Michigan State University College of Osteopathic MedicineClass of 2006
Certifications & Licensure
IL State License 2023 - 2026
MI State License 2006 - 2026
OH State License 2024 - 2026
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2013
Publications & Presentations
PubMed
- 2 citationsHumoral immune response to COVID-19 mRNA vaccines in patients with relapsing multiple sclerosis treated with ofatumumab.Amit Bar-Or, Rany Aburashed, Angel R Chinea, Barry A Hendin, Elisabeth Lucassen
Multiple Sclerosis and Related Disorders. 2023-11-01 - 3 citationsConfirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc A...Samuel F. Hunter, Rany A Aburashed, Raed Alroughani, Andrew T. Chan, Dominique Dive
Neurology and Therapy. 2021-06-24 - 5 citationsCNS-disseminated Angiostrongylus cantonensis mimicking atypical demyelinating disease.Daniel Long, Kemar E. Green, Talal Derani, Nicholas Decker, Robert J. Pace
Neurology(R) Neuroimmunology & Neuroinflammation. 2019-11-01
Press Mentions
Neurogen Biomarking Announces Global Agreement with Quanterix for Use of Blood Biomarker Assay in Its Patient-Initiated Blood Test to Support Early Detection of Dementia and Mild Cognitive Impairment Due to Alzheimer’s DiseaseFebruary 19th, 2025- Neurogen Biomarking Announces Collaboration with Linus Health Bringing Easy Access to Cutting-Edge Technology to Support Early Detection of Mild Cognitive Impairment and Dementia Due to Alzheimer's DiseaseJanuary 14th, 2025
- Michigan Health System Selected as New Owner of Warren HospitalsNovember 4th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
